Accounts Payable - Novogene Co Ltd (SSE:688315) - Alpha Spread

Novogene Co Ltd
SSE:688315

Watchlist Manager
Novogene Co Ltd Logo
Novogene Co Ltd
SSE:688315
Watchlist
Price: 9.15 CNY -3.17%
Market Cap: 3.8B CNY
Have any thoughts about
Novogene Co Ltd?
Write Note

Novogene Co Ltd
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Novogene Co Ltd
Accounts Payable Peer Comparison

Comparables:
603259
300759
2269
300347
1548

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
Novogene Co Ltd
SSE:688315
Accounts Payable
ÂĄ159m
CAGR 3-Years
17%
CAGR 5-Years
22%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Accounts Payable
ÂĄ2B
CAGR 3-Years
15%
CAGR 5-Years
34%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Accounts Payable
ÂĄ503m
CAGR 3-Years
23%
CAGR 5-Years
33%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Accounts Payable
ÂĄ2.2B
CAGR 3-Years
60%
CAGR 5-Years
54%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Accounts Payable
ÂĄ227.1m
CAGR 3-Years
23%
CAGR 5-Years
61%
CAGR 10-Years
38%
Genscript Biotech Corp
HKEX:1548
Accounts Payable
$40m
CAGR 3-Years
14%
CAGR 5-Years
23%
CAGR 10-Years
N/A

See Also

What is Novogene Co Ltd's Accounts Payable?
Accounts Payable
159m CNY

Based on the financial report for Dec 31, 2023, Novogene Co Ltd's Accounts Payable amounts to 159m CNY.

What is Novogene Co Ltd's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
22%

Over the last year, the Accounts Payable growth was 21%. The average annual Accounts Payable growth rates for Novogene Co Ltd have been 17% over the past three years , 22% over the past five years .

Back to Top